Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today it will provide business updates and report its first quarter 2026 ...
The startup’s parent company moved its headquarters to Singapore in June 2025, shortly before the deal Read more at The ...
Autonomous robots will be deployed at Punggol Digital District to explore various use cases, among other plans Read more at ...
Instead of going down the surgical route like Neuralink, Sabi is taking a much simpler and safer approach. Its beanie uses ...
Imagine you are wearing a cap that can decode your thoughts. At first, the idea sounds absurd and not closer to reality. To ...
Jeffrey Young named Chief Financial Officer; Ganesh Mugundu, M.Pharm, Ph.D., appointed Vice President, Head of Clinical Development; and Richard ...
Every few years, a new sensing capability reshapes an entire product category. Brain data is next, and this time, most ...
NVIDIA has significantly outperformed the broader market over the past year, and analysts are highly optimistic about the ...
When research, infrastructure, and product development come together, we have a real opportunity to reshape education ...
The Latest Breakthrough Study from Leaps by Bayer and BCG reveals why optimism varies by technology, region, and context, ...
NVIDIA will release its first-quarter earnings next month, and analysts anticipate a triple-digit bottom-line growth.
The deal, through IKS Health’s US subsidiary, will be funded by a loan of up to $670 million secured for a five-year term ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results